- JP-listed companies
- Nippon Shinyaku Co.,Ltd.
- Financials
- EBITDA margin (%)
Nippon Shinyaku Co.,Ltd. (4516)
Market cap
¥357.7B
P/E ratio
13.1x
Nippon Shinyaku manufactures and sells pharmaceuticals and functional foods through six subsidiaries operating in Japan, the US, and China.
| Period End | EBITDA margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 25.9 | +0.12% |
| Mar 31, 2024 | 25.8 | +6.19% |
| Mar 31, 2023 | 24.3 | -10.81% |
| Mar 31, 2022 | 27.3 | +12.05% |
| Mar 31, 2021 | 24.4 | +13.01% |
| Mar 31, 2020 | 21.6 | +2.74% |
| Mar 31, 2019 | 21 | +7.19% |
| Mar 31, 2018 | 19.6 | +7.82% |
| Mar 31, 2017 | 18.1 | +38.93% |
| Mar 31, 2016 | 13.1 | -6.92% |
| Mar 31, 2015 | 14 |